Literature DB >> 19059503

Compound-heterozygous Marfan syndrome.

F S Van Dijk1, B C Hamel, Y Hilhorst-Hofstee, B J M Mulder, J Timmermans, G Pals, J M Cobben.   

Abstract

We report two families in which the probands have compound-heterozygous Marfan syndrome (MFS). The proband of family 1 has the R2726W FBN1 mutation associated with isolated skeletal features on one allele and a pathogenic FBN1 mutation on the other allele. The phenotype of the compound-heterozygous probands appears to be more severe than that of their heterozygous family members which underlines the possibility that certain trans-located FBN1 mutations might act as modifiers of phenotype explaining some of the intrafamilial variability in Marfan syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059503     DOI: 10.1016/j.ejmg.2008.11.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  11 in total

Review 1.  Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.

Authors:  Alain Li-Wan-Po; Bart Loeys; Peter Farndon; David Latham; Caroline Bradley
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 2.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

Authors:  Lynn Y Sakai; Douglas R Keene; Marjolijn Renard; Julie De Backer
Journal:  Gene       Date:  2016-07-18       Impact factor: 3.688

3.  Actionable, pathogenic incidental findings in 1,000 participants' exomes.

Authors:  Michael O Dorschner; Laura M Amendola; Emily H Turner; Peggy D Robertson; Brian H Shirts; Carlos J Gallego; Robin L Bennett; Kelly L Jones; Mari J Tokita; James T Bennett; Jerry H Kim; Elisabeth A Rosenthal; Daniel S Kim; Holly K Tabor; Michael J Bamshad; Arno G Motulsky; C Ronald Scott; Colin C Pritchard; Tom Walsh; Wylie Burke; Wendy H Raskind; Peter Byers; Fuki M Hisama; Deborah A Nickerson; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

4.  Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation.

Authors:  J J J Aalberts; A G Schuurman; G Pals; B J C Hamel; G Bosman; Y Hilhorst-Hofstee; D Q C M Barge-Schaapveld; B J M Mulder; M P van den Berg; J P van Tintelen
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

5.  Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome.

Authors:  Guglielmina Pepe; Stefano Nistri; Betti Giusti; Elena Sticchi; Monica Attanasio; Cristina Porciani; Rosanna Abbate; Robert O Bonow; Magdi Yacoub; Gian Franco Gensini
Journal:  BMC Med Genet       Date:  2014-02-24       Impact factor: 2.103

Review 6.  Skeletal manifestations of Marfan syndrome associated to heterozygous R2726W FBN1 variant: sibling case report and literature review.

Authors:  Octavio D Reyes-Hernández; Carmen Palacios-Reyes; Sonia Chávez-Ocaña; Enoc M Cortés-Malagón; Patricia Garcia Alonso-Themann; Víctor Ramos-Cano; Julián Ramírez-Bello; Mónica Sierra-Martínez
Journal:  BMC Musculoskelet Disord       Date:  2016-02-15       Impact factor: 2.362

7.  Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families.

Authors:  Nadia Akawi; Jeremy McRae; Morad Ansari; Meena Balasubramanian; Moira Blyth; Angela F Brady; Stephen Clayton; Trevor Cole; Charu Deshpande; Tomas W Fitzgerald; Nicola Foulds; Richard Francis; George Gabriel; Sebastian S Gerety; Judith Goodship; Emma Hobson; Wendy D Jones; Shelagh Joss; Daniel King; Nikolai Klena; Ajith Kumar; Melissa Lees; Chris Lelliott; Jenny Lord; Dominic McMullan; Mary O'Regan; Deborah Osio; Virginia Piombo; Elena Prigmore; Diana Rajan; Elisabeth Rosser; Alejandro Sifrim; Audrey Smith; Ganesh J Swaminathan; Peter Turnpenny; James Whitworth; Caroline F Wright; Helen V Firth; Jeffrey C Barrett; Cecilia W Lo; David R FitzPatrick; Matthew E Hurles
Journal:  Nat Genet       Date:  2015-10-05       Impact factor: 38.330

8.  Clinically relevant variants in a large cohort of Indian patients with Marfan syndrome and related disorders identified by next-generation sequencing.

Authors:  Shalini S Nayak; Pauline E Schneeberger; Siddaramappa J Patil; Karegowda M Arun; Pujar V Suresh; Viralam S Kiran; Sateesh Siddaiah; Shreesha Maiya; Shrikanth K Venkatachalagupta; Neethukrishna Kausthubham; Fanny Kortüm; Isabella Rau; Alexandra Wey-Fabrizius; Lotte Van Den Heuvel; Josephina Meester; Lut Van Laer; Anju Shukla; Bart Loeys; Katta M Girisha; Kerstin Kutsche
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

9.  Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family.

Authors:  Agnete Jørgensen; Toril Fagerheim; Svend Rand-Hendriksen; Per I Lunde; Torgrim O Vorren; Melanie G Pepin; Dru F Leistritz; Peter H Byers
Journal:  Eur J Hum Genet       Date:  2014-09-10       Impact factor: 4.246

10.  Autosomal dominant Marfan syndrome caused by a previously reported recessive FBN1 variant.

Authors:  Eline Overwater; Rifka Efrat; Daniela Q C M Barge-Schaapveld; Phillis Lakeman; Marjan M Weiss; Alessandra Maugeri; J Peter van Tintelen; Arjan C Houweling
Journal:  Mol Genet Genomic Med       Date:  2018-11-28       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.